This paper is in the following e-collection/theme issue:

Patient-Reported Outcome Measures (PROMs) (325) Innovations and Technology in Cancer Care (463) Participatory Medicine & E-Patients (829) Chemotherapy and Side Effects Management (85) Research Instruments, Questionnaires, and Tools (665) Questionnaires and Research Instruments for Cancer Patients (18)

Published on in Vol 23, No 8 (2021): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29271, first published .
The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial

The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial

The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial

Authors of this article:

Andreas Trojan1 Author Orcid Image ;   Nicolas Leuthold2 Author Orcid Image ;   Christoph Thomssen3 Author Orcid Image ;   Achim Rody4 Author Orcid Image ;   Thomas Winder5, 6 Author Orcid Image ;   Andreas Jakob7 Author Orcid Image ;   Claudine Egger8 Author Orcid Image ;   Ulrike Held9 Author Orcid Image ;   Christian Jackisch10 Author Orcid Image
Article Authors Cited by (5) Tweetations (5) Metrics

Journals

  1. Kutzleben M, Galuska J, Hein A, Griesinger F, Ansmann L. Needs of Lung Cancer Patients Receiving Immunotherapy and Acceptance of Digital and Sensor-Based Scenarios for Monitoring Symptoms at Home—A Qualitative-Explorative Study. International Journal of Environmental Research and Public Health 2022;19(15):9265 View
  2. Trojan A, Roth S, Atassi Z, Kiessling M, Zenhaeusern R, Kadvany Y, Schumacher J, Kullak-Ublick G, Aapro M, Eniu A. Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. JMIR Cancer 2024;10:e54178 View
  3. Trojan A, Kühne C, Kiessling M, Schumacher J, Dröse S, Singer C, Jackisch C, Thomssen C, Kullak-Ublick G. Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data. JMIR Formative Research 2024;8:e55917 View
  4. Trojan A, Laurenzi E, Jüngling S, Roth S, Kiessling M, Atassi Z, Kadvany Y, Mannhart M, Jackisch C, Kullak-Ublick G, Witschel H. Towards an early warning system for monitoring of cancer patients using hybrid interactive machine learning. Frontiers in Digital Health 2024;6 View
  5. Crafoord M, Ekstrand J, Sundberg K, Nilsson M, Fjell M, Langius-Eklöf A. Mobile Electronic Patient-Reported Outcomes and Interactive Support During Breast and Prostate Cancer Treatment: Health Economic Evaluation From Two Randomized Controlled Trials. JMIR Cancer 2025;11:e53539 View